Australia markets open in 8 hours 34 minutes

InVivo Therapeutics Holdings Corp (04I.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.3060+0.0020 (+0.66%)
As of 08:00AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-9,327
-10,490
-9,895
-9,074
Depreciation & amortisation
420
445
372
329
Stock-based compensation
187
159
315
215
Change in working capital
-1,410
-596
354
-1,004
Accounts payable
-741
12
124
-461
Other working capital
-10,173
-10,642
-8,931
-9,575
Net cash provided by operating activities
-10,128
-10,482
-8,854
-9,534
Cash flows from investing activities
Investments in property, plant and equipment
-45
-160
-77
-41
Net cash used for investing activities
50
-160
-77
-41
Cash flows from financing activities
Common stock issued
-
7,962
0
22,119
Net cash used provided by (used for) financing activities
-
7,962
8,509
22,462
Net change in cash
-2,116
-2,680
-422
12,887
Cash at beginning of period
10,747
19,181
19,603
6,716
Cash at end of period
8,631
16,501
19,181
19,603
Free cash flow
Operating cash flow
-10,128
-10,482
-8,854
-9,534
Capital expenditure
-45
-160
-77
-41
Free cash flow
-10,173
-10,642
-8,931
-9,575